A staggering 1 in 8 women in the United States will be diagnosed with breast cancer in their lifetime. In 2025 alone, an estimated 316,950 women and 2,800 men are expected to be diagnosed with ...
This October, as the American Cancer Society (ACS) marks the 40 th anniversary of Breast Cancer Awareness Month, the fight against breast cancer remains as important as ever. More than 316,000 women ...
Hosted on MSN
Q&A: Breast cancer facts that could save lives
October is Breast Cancer Awareness Month, a time to spotlight a disease that will affect hundreds of thousands of Americans this year. In the U.S., a new case of breast cancer is diagnosed about every ...
Avan Armaghani, MD, reviews three key topics in the management of hormone receptor (HR)–positive, human epidermal growth factor receptor 2 (HER2)–negative breast cancer to be explored at this year’s ...
Atezolizumab, combined with chemotherapy, did not improve survival in high-risk triple-negative breast cancer and had higher severe adverse events. A Swedish study found 30% of breast cancers were ...
The National Institute for Health and Care Excellence (NICE) has recommended ribociclib (Kisqali, Novartis) for routine NHS use in adjuvant treatment of hormone receptor-positive, HER2-negative early ...
A woman’s annual mammogram can sometimes feel like a chore. While most chores can be put off, it’s important to prioritize a screening for breast cancer. Breast cancer is the second most common cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results